Suggestions
Danielle Wolf
US Market Access Marketing, Oncology at AbbVie
Professional Background
Danielle Wolf boasts an impressive career in the pharmaceutical and healthcare industries, marked by substantial contributions and leadership roles across various sectors. Currently, since July 2020, she holds a key position as the US Market Access Marketing leader for Oncology at AbbVie, where she is responsible for driving the marketing strategies for the pipeline products addressing critical areas such as myelofibrosis (MF), multiple myeloma (MM), myelodysplastic syndromes (MDS), and Venclexta® for acute myeloid leukemia (AML).
Before joining AbbVie, Danielle enjoyed a successful 11-year tenure with Pfizer, where her career progressed through various commercial roles that allowed her to hone her skills in brand management and payer access. Here, she garnered extensive experience across multiple therapeutic areas, including significant involvement in the Latin American market—a testament to her capability in navigating diverse healthcare landscapes. Furthermore, her initial years at Pfizer were spent in Research & Development, giving her a strong scientific foundation to complement her marketing acumen.
Following her impactful period at Pfizer, Danielle took on a leading role at Janssen, part of Johnson & Johnson, starting as the Pricing Lead for Emerging Markets within Janssen’s entire portfolio. Her strategic expertise quickly propelled her into the role of Global Pricing Director for Oncology and Vaccines, where she focused on solid tumors, hematology, and vaccines, emphasizing markets within the US and EU5. Her multifaceted experience in pricing and market access positions her as a thought leader in pharmaceutical marketing and an expert in driving access to innovative therapies.
Education and Achievements
Danielle Wolf's educational background is as impressive as her professional accomplishments. She earned her Bachelor of Science in Biology from Lehigh University, a strong foundation that has supported her throughout her career. Passionate about continuing her education, Danielle pursued an MBA, specializing in Marketing and Communications & Media Management, with a focus on International Business from the prestigious Fordham Gabelli School of Business. To further enhance her project management skills—crucial in the fast-paced pharmaceutical sector—she attained a Master of Science in Project Management from The George Washington University School of Business.
Her commitment to academic excellence and professional growth reflects her determination to succeed and lead in competitive environments. Coupled with her experiences as a competitive swimmer since the age of six, where she competed at the Division I level at university, Danielle's discipline and resilience shine through in every facet of her life.
Achievements
Danielle's career is characterized by numerous notable achievements that illustrate her expertise and leadership in the pharmaceutical industry. During her time at AbbVie, she leads crucial initiatives that strategically position the oncology pipeline products within an ever-evolving market landscape. Her ability to navigate through complexities of market access and insurance dynamics has enabled her to effectively increase the visibility and accessibility of life-saving therapies to patients and healthcare providers alike.
While at Janssen, Danielle was instrumental in shaping pricing strategies that supported the expansion of critical oncology and vaccine products into emerging global markets. Her insights and strategic direction have significantly impacted how these products are perceived and accessed in key areas globally, showcasing her adaptability in various international markets.
At Pfizer, her roles, ranging from a Senior Regional Brand Manager for Vaccines in Latin America to the Director of Payer Insights & Access Strategist, underscore her capacity to lead multinational teams and influence key stakeholders, including payers, health systems, and patient advocacy groups. Her involvement in pricing and access strategies has consistently positioned her as a valuable asset in any organization she has been part of.
With a career dedicated to improving patient outcomes and expanding access to essential medications, Danielle Wolf embodies the essence of a healthcare professional committed to innovation and collaboration. Her journey thus far reflects a blend of scientific expertise, strategic insight, and a genuine desire to make a difference in the healthcare landscape.